MAIA Biotechnology (MAIA) Interest Coverage Ratio (2021 - 2024)
MAIA Biotechnology's (MAIA) quarterly Interest Coverage Ratio came in at 178735.86 in Q4 2024, up 462.72% quarter-over-quarter from 49276.09 in Q3 2024.
Analysis
MAIA Biotechnology (MAIA) Interest Coverage Ratio (2021 - 2024) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Interest Coverage Ratio for 4 consecutive years, with 178735.86 the latest figure, recorded in Q4 2024.
- On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 178735.86 in Q4 2024; TTM through Dec 2024 was 292365.69, a 9841.87% decrease from a year earlier, with the FY2024 full-year figure at 297494.91, down 10016.29% from the prior year.
- Interest Coverage Ratio was 178735.86 for Q4 2024 at MAIA Biotechnology, up from 49276.09 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 178735.86 in Q4 2024 and troughed at 4955643.0 in Q3 2023.
- A 4-year average of 540733.57 and a median of 2719.91 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio tumbled 166787.25% in 2023 and jumped 99.01% in 2024, its largest moves.
- Over 4 years, Interest Coverage Ratio stood at 4.95 in 2021, then tumbled by 16370.75% to 815.04 in 2022, then slumped by 607924.21% to 4955643.0 in 2023, then soared by 103.61% to 178735.86 in 2024.
- The last three Interest Coverage Ratio figures came in at 178735.86 (Q4 2024), 49276.09 (Q3 2024), and 4955643.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | MAIA Biotechnology | 79.34 Mn | 51.74 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 178,735.86 |
| Sep 30, 2024 | -49,276.09 |
| Sep 30, 2023 | -4.96 Mn |
| Jun 30, 2023 | -2,719.91 |
| Mar 31, 2023 | -812.95 |
| Dec 31, 2022 | -815.04 |
| Sep 30, 2022 | -2,969.46 |
| Jun 30, 2022 | -33,096.58 |
| Sep 30, 2021 | -4.95 |